Population
CRI-G1 insulin-secreting cells
Design
Preclinical
Authors
Loading...
Certain barbiturates may impair beta-cell insulin release via KATP blockade; leaves open in vivo relevance and clinical glucose effects.
Barbiturates inhibit ATP-K+ channels in insulin-secreting cells, likely through a membrane-mediated mechanism driven by hydrophobicity.
Kozlowski et al. (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: